Abstract
Aldosterone levels are increased in primary aldosteronism (PA) and might be triggered in several cardiovascular disorders. The aim of our study was to assess the analytical validity of a novel automated aldosterone immunoassay. Method comparison was also performed with a reference radioimmunoassay. We report for the first time the analytical validity of the LIAISON® aldosterone automated immunoassay. Such automated assay might therefore facilitate the screening of PA and risk stratification of cardiovascular diseases.